Related Experiment Video

Updated: Aug 12, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger

D Lazzereschi1, A Ranieri, G Mincione

  • 1Dipartimento di Medicina Sperimentale, Università La Sapienza, Rome, Italy.

Cancer Research
|May 15, 1997
PubMed

Insights

Transforming growth factor beta receptor type II (TbetaRII) expression is reduced in thyroid carcinomas. This loss of TbetaRII may drive thyroid cancer progression by enabling cells to evade TGF-beta growth inhibition.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Transforming growth factor beta (TGF-beta) regulates thyroid epithelial cell growth and differentiation.
  • TGF-beta signaling involves a receptor complex including TGF-beta receptor type II (TbetaRII).
  • Reduced TbetaRII expression is linked to resistance to TGF-beta's anti-proliferative effects.

Purpose of the Study:

  • To investigate TbetaRII expression in various human thyroid tumors.
  • To determine the correlation between TbetaRII expression levels and thyroid tumor aggressiveness.
  • To elucidate the role of TbetaRII loss in thyroid cancer progression.

Main Methods:

  • Analysis of TbetaRII messenger RNA (mRNA) expression in thyroid tissues.
  • Immunohistochemical analysis using specific anti-TbetaRII antibodies.
  • Comparison of TbetaRII expression in benign lesions, carcinomas, and anaplastic tumors versus normal thyroid tissue.

Main Results:

  • Significantly reduced TbetaRII mRNA expression was observed specifically in thyroid carcinomas compared to normal thyroid tissues.
  • Immunohistochemical analyses corroborated the reduced expression of TbetaRII.
  • TbetaRII expression levels correlated with tumor aggressiveness, being lowest in advanced carcinomas.

Conclusions:

  • Loss of TbetaRII expression is a feature of thyroid carcinomas.
  • Reduced TbetaRII contributes to thyroid cancer progression by impairing TGF-beta-mediated growth inhibition.
  • Targeting TbetaRII pathways could be a strategy for thyroid cancer treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...